IM Cannabis (IMCC) EBIT (2020 - 2026)

IM Cannabis' EBIT history runs 7 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

• In Q1 2026, EBIT fell 1209.91% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$4.1 million (up 75.3% YoY), while the FY2025 annual figure was -$8.3 million, down 11.16% from the prior year.
• EBIT was -$1.2 million for Q1 2026 at IM Cannabis, up from -$5.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $257.2 million in Q4 2022 to a low of -$98.3 million in Q3 2022.
• Historically, EBIT has averaged $6.5 million across 5 years, with a median of -$2.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: EBIT slumped 2087.26% in 2022, then jumped 254.08% in 2025.
• A 5-year view of EBIT shows it stood at $257.2 million in 2022, then tumbled by 101.74% to -$4.5 million in 2023, then plunged by 233.05% to -$14.9 million in 2024, then surged by 62.89% to -$5.5 million in 2025, then soared by 77.87% to -$1.2 million in 2026.
• The last three EBIT figures came in at -$1.2 million (Q1 2026), -$5.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.